speb/financial-data huggingface dataset:
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 20510167000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 20493904000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 7520927.74
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Tax Provision: 503216000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.23
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 1144876000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -109024000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 56167996000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 27760931000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 13482253000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 20510167000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Total Expenses: 29495110000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 35657829000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 36720991000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 11910487000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 183595000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 171076000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 33376000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 33376000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 979134000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Working Capital: -4300337000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Write Off: 7235000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 7886600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3779100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 442600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 237100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 309600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 26800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2121500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 309600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 21362000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 2000300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 16524600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 72800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 5855300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 5928100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 18833200000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 33400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 14900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 34898400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 9393500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 37672100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 17700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 442600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Investmentsin Joint Venturesat Cost: 3565800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 164300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 10454800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 10619100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 3565800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 51900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 16283300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 34898400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 21347100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 4158200000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 61923000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1157600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 3028900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 21052400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 14900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 49500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 29000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 32898100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 2094700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 7886600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 61923000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 21362000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 21347100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 72900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 55518500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 31816800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 16547200000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 21362000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 34156500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 38993900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 15323300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -2308600000.00
INDIAGLYCO.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 9646700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 2159800000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 37682600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 8632200000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 10687712000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10687712000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3649707000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3649707000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -6506890000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6506890000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 395855000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 395855000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -52879000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -52879000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Amortization: 2708000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 2708000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 441900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 441900000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 61925449.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 61914894.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Basic EPS: 37.29
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 10.34
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 269600000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1418317000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1418317000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -7604700000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 872605000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 872605000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 309615000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 309615000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 68372000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 68372000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 546925000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 546925000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -245900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 68372000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 68372000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -646000000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Change In Payable: -2198600000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 1711700000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1132900000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -201200000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 309615000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 309615000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -245900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 22558766000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 22558766000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1019254000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1019254000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 24078500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5338900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 18162218000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 18162218000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 202756000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 202756000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Current Debt: 7641815000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 7641815000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 7844571000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 7844571000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 23210426000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 23210426000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 30400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 30400000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Depreciation: 1152000000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1152000000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1152000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 325900000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1152000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 325900000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 61925449.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 61914894.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Diluted EPS: 37.29
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 10.34
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 640200000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 18125000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 18125000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — EBIT: 4566900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — EBIT: 1263200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — EBITDA: 5718900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1589100000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 68400000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 3537600000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 1873484000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1873484000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -3983600000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -10200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 511413000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 13734000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 13734000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3702586000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3702586000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 45785621000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 45785621000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Gross Profit: 13604100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 3293300000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Interest Expense: 1643700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 445300000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1643700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 445300000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Interest Income: 143771000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 143771000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1653100000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 167700000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Inventory: 11708803000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 11708803000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 40601481000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 40601481000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -7359900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 17494000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 17494000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 441900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 441900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 3813084000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 3813084000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 8602700000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 2206231000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 2206231000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 669849000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 669849000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 10400900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 10400900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 11070749000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 11070749000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 8602700000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -3767500000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 3813084000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3813084000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 52700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 52700000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 40045697000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 40045697000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Net Debt: 17974343000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 17974343000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 47400000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Income: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Income: 640200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 640200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 640200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 640200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 640200000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 2459200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 640200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Interest Income: -1643700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -445300000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 4835200000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 4835200000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1643700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -445300000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 39278731000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 39278731000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -7527600000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 22545032000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 22545032000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 28387000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 28387000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4423761000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4423761000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 52674000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 52674000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 470367000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 470367000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 5718900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1589100000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Normalized Income: 2309200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 640200000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 3621100000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Operating Income: 3957400000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Operating Income: 1133500000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 37682600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 8632200000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 61923000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 61923000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1397700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1397700000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1787900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1787900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 22249200000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 22249200000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 13734000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 13734000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 7455000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 7455000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 1512400000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 63800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 63800000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 28400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 28400000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 145500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 15900000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 7267800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1528300000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 2909551000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 2909551000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 1096122000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1096122000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 296733000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 296733000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 478553000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 478553000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Other Special Charges: -10153000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Payables: 13781352000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 13781352000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 30394000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 30394000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 317772000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 317772000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Pretax Income: 2923200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 817900000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -204700000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -7604700000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 8916711000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 8916711000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 24078500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5338900000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1152000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 325900000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 101503000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 101503000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -3767500000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 705994000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 705994000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 20713188000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 20713188000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 0.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 77100000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 717223000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1228636000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 61923000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 22558766000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 22558766000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 22545032000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 22545032000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Tax Provision: 614000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 177700000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.21
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 936284000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 936284000.00
INDIAGLYCO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -202100000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 61760988000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 61760988000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 32959666000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 32959666000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 18915320000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 18915320000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 22558766000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 22558766000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Total Expenses: 33725200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 7498700000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 39202222000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 39202222000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 43598770000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 43598770000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 15991796000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 15991796000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 272741000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 165964000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 165964000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 911153000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 911153000.00
INDIAGLYCO.NS balance_sheet (annual, 2025-03-31) — Working Capital: -5048208000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -5048208000.00
INDIAGLYCO.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 2478000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 10404600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 61918850.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 11.83
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 6774700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 344500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 344500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 61918850.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 11.83
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — EBIT: 1352100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 1696600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 3629900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 446800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 446800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Income: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -446800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -446800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1696600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 732500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Operating Income: 1151900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 10404600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 14000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1822900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 905300000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 6774700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 344500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 172800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
INDIAGLYCO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 9252700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 2871900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 10922000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8233400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3081600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 441100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 61902950.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 10.51
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 773600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 309600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 178700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1529400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 309600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 23936300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 2669400000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 6858500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 16754600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 212100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 8036300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 8248400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 20252200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 384800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 384800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 61902950.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 10.51
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — EBIT: 1328900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1713700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 12400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 40177100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 4063500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 492800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 492800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 10834700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 43712100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 17300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 441100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 4112700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 561500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 11739500000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 12301000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 4112700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 19597100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Income: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -492800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -492800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 40177100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 23923900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 4609100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 56600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1713700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 650600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Operating Income: 1191600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 10922000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 61923000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1262600000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 940000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 23626700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 12400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 52300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 27800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 21700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2166000000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 37507700000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1350700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 8233400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 35000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 836100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 6858500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 384800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 61923000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 23936300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 23923900000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 185500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.22
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 46300000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 61572400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 35675800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 20549400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 23936300000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 9730400000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 37636100000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 44817800000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 17383900000.00
INDIAGLYCO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -3497600000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2764300000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 11024000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 62622799.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 10.79
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6917200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 412200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 412200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 62622799.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 10.79
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 675700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — EBIT: 1374200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1786400000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 4106800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 468100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 468100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Income: 675700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 675700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 675700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 675700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 675700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 675700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -468100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -468100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1794700000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 681889504.47
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1342500000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 11024000000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 7400000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1999800000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 906100000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6917200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 412200000.00
INDIAGLYCO.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -8300000.00